PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+1.86%)
As of: Oct 22, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Inventory (2011 - 2012)

Updated

PharmaCyte Biotech (PMCB) reported Inventory of $9,620 for fiscal Q1 2013 (quarter ended Jul 31, 2012), up 26.3% from $7,617 a year earlier and up 40.5% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Inventory (2011 - 2012) Analysis & Trends

At the end of FY2012 (ended Apr 30, 2012), PharmaCyte Biotech posted Inventory of $6,846, down 63.4% from FY2011.

  • By fiscal year, Inventory came in at $18,706 in FY2011.
  • The fiscal Q1 2013 figure ranks as the highest quarterly Inventory since fiscal Q4 2011.
  • Per Business Quant data, the three fiscal quarters before Q1 2013 came in at $6,846 (Q4 2012), $2,307 (Q3 2012) and $4,518 (Q2 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 16.79 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 15.38 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 5.13 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 6.22 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 6.22 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.95 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 9.95 Bn
10 PharmaCyte Biotech 3.79 Mn -69.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2012 9,620.00
Apr 30, 2012 6,846.00
Jan 31, 2012 2,307.00
Oct 31, 2011 4,518.00
Jul 31, 2011 7,617.00
Apr 30, 2011 18,706.00
API Access

PharmaCyte Biotech Inventory API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=inventory&ticker=PMCB&period=max&api_key=YOUR_API_KEY